Cited by 24Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia

Vijayaraghavan, Swetha, Maetzler, Walter, Reimold, Matthias, Lithner, Christina Unger, Liepelt‐Scarfone, Inga, Berg, Daniela, Darreh‐Shori, Taher·2014·Alzheimer's & Dementia

Abstract

Apolipoprotein E ε4 allele (APOE ε4) increases the apolipoprotein E (apoE) protein levels in Alzheimer's disease (AD) cerebrospinal fluid (CSF). Thus, we hypothesized that apoE levels were also associated with the APOE genotype, and amyloid‐β (Aβ)‐associated clinical, functional, and imaging parameters in patients with Lewy body‐associated disorders (LBD). Indeed, similar to AD, patients with LBD displayed high CSF apoE levels (greatest in patients with dementia with LBD), and this was linked to APOE ε4. High CSF apoE protein correlated positively with CSF soluble amyloid precursor protein, total tau, and cortical and striatal Pittsburgh compound B retention; and correlated negatively with CSF Aβ 42, cognitive tests scores, and glucose uptake ratio in the temporal and parietal cortices. APOE ε4‐triggered accumulation of apoE in CSF is related to Aβ‐associated clinical and functional imaging parameters in LBD. Accordingly, therapeutic strategies aimed at reducing apoE levels in the brain should be explored not only in AD but also in LBD, particularly when accompanied with dementia.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2013.03.010

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human studies of cerebrospinal fluid with various Alzheimer disease-related outcomes are conflicting, including differences in APOE genotype stratified analyses.

    “Human studies of cerebrospinal fluid with various Alzheimer diseaseerelated outcomes are conflicting, including differences in the APOE genotype stratified analyses [105,106].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vijayaraghavan, S., Maetzler, W., Reimold, M., Lithner, C. U., Liepelt‐Scarfone, I., Berg, D., & Darreh‐Shori, T.
Affiliations
  • Karolinska Institutet (SE)
  • German Center for Neurodegenerative Diseases (DE)
  • University of Tübingen (DE)
Corresponding author
Darreh‐Shori, Taher
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2013-08-26
Volume
10
Issue
5
Pages
530
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2082564633
Cited by
24
References
6
Citations by year
2025: 1 · 2024: 6 · 2020: 1 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 1
FWCI
2.32
Type
journal article
Language
en
Open access
closed
Locations
  • Alzheimer s & Dementia (publishedVersion)
  • PubMed (publishedVersion)
  • DZNE Pub (submittedVersion)
Funders
  • American Liver Foundation
  • Stockholms Läns Landsting
  • Karolinska Institutet
  • Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
  • Stiftelsen Olle Engkvist Byggmästare
  • Stiftelsen för Gamla Tjänarinnor
  • Gun och Bertil Stohnes Stiftelse
  • Åke Wiberg Stiftelse
  • Stiftelsen Ragnhild och Einar Lundströms Minne
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
apolipoprotein E, APOE ε4
MeSH terms
Aged, Aged, 80 and over, Aniline Compounds, Apolipoproteins E, Brain, Carbon Radioisotopes, Female, Glucose, Humans, Male, Middle Aged, Neuropsychological Tests, Peptide Fragments, Thiazoles, Cohort Studies, Biomarkers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Radiopharmaceuticals, Fluorodeoxyglucose F18, Lewy Body Disease, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review